EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Psychosocial impact at the time of a rare disease diagnosis

Juan Benito-Lozano iD, Greta Arias-Merino, Mario Gómez-Martínez, Beatriz Arconada-López, Begoña Ruiz-García, Manuel Posada de la Paz iD, Verónica Alonso-Ferreira iD

PLOS ONE · 28.07.2023 · 18 (7) · e0288875

DOI: 10.1371/journal.pone.0288875 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 28.07.2023. Verfasst von Juan Benito-Lozano und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Rare Diseases Research (IIER), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. Hauptthemen laut MEDLINE: Rare Diseases, Delayed Diagnosis. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science, Innovation and Universities, Spanish State Research Agency, State R&D.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over half of all persons with rare diseases (RDs) in Spain experience diagnostic delay (DD) but little is known about its consequences. This study therefore aimed to analyze the psychological impact of obtaining a diagnosis of an RD, and to ascertain what social determinants are influenced and what the personal consequences are, according to whether or not patients experienced DD. Data were obtained from a purpose-designed form completed by persons registered at the Spanish Rare Diseases Patient Registry. The following were performed: a descriptive analysis; a principal component analysis (PCA); and logistic regressions. Results revealed that while searching for a diagnosis, people who experienced DD were more in need of psychological care than those diagnosed in less than one year (36.2% vs 23.2%; p = 0.002; n = 524). The PCA identified three principal components, i.e., psychological effects, social implications, and functional impact. Reducing DD would improve psychological effects, such as irritability (OR 3.6; 95%CI 1.5–8.5), frustration (OR 3.4; 95%CI 1.7–7.1) and concentration on everyday life (OR 3.3; 95%CI 1.4–7.7). The influence of the social implications and functional repercussions of the disease was greater in persons with DD (scores of 22.4 vs 20 and 10.6 vs 9.4, respectively) in terms of the difficulty in explaining symptoms to close friends and family (3.3 vs 2.9), and loss of independence (3.3 vs 2.9). In conclusion, this is the first study to analyze the psychosocial impact of diagnosis of RDs in Spain and one of few to assess it in the patients themselves, based on data drawn from a purpose-designed form from a national registry open to any RD. People affected by RDs who underwent DD experienced greater psychosocial impact than did those who were diagnosed within the space of one year.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rare DiseasesDelayed DiagnosisHumansSpain

Autor:innen und Institutionen

  • Institute of Rare Diseases Research (IIER), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • Universidad Nacional de Educación a Distancia (UNED), Madrid, Spain.
  • Spanish Federation of Rare Diseases (FEDER), Federación Española de Enfermedades Raras, Madrid, Spain.
  • The State Reference Center for Assistance to People Living with Rare Diseases and their Families (Creer), Centro de Referencia Estatal de Atención a Personas con Enfermedades Raras y sus Familias, dependiente del IMSERS…
  • Undiagnosed Diseases Network International (UDNI), Madrid, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, España.

ORCID-Profile: Juan Benito-Lozano, Manuel Posada de la Paz, Verónica Alonso-Ferreira

Förderung

  • Ministry of Science, Innovation and Universities
  • Spanish State Research Agency, State R&D

Zitieren

APA

Benito-Lozano, J., Arias-Merino, G., Gómez-Martínez, M., Arconada-López, B., Ruiz-García, B., Posada de la Paz, M., & Alonso-Ferreira, V. (2023). Psychosocial impact at the time of a rare disease diagnosis. PLOS ONE, 18(7), e0288875. https://doi.org/10.1371/journal.pone.0288875

Vancouver

Benito-Lozano J, Arias-Merino G, Gómez-Martínez M, Arconada-López B, Ruiz-García B, Posada de la Paz M, et al. Psychosocial impact at the time of a rare disease diagnosis. PLOS ONE. 2023;18(7):e0288875. doi:10.1371/journal.pone.0288875

BibTeX
@article{BenitoLozano2023,
  author = {Benito-Lozano, Juan and Arias-Merino, Greta and Gómez-Martínez, Mario and Arconada-López, Beatriz and Ruiz-García, Begoña and Posada de la Paz, Manuel and Alonso-Ferreira, Verónica},
  title = {Psychosocial impact at the time of a rare disease diagnosis},
  journal = {PLOS ONE},
  year = {2023},
  volume = {18},
  number = {7},
  pages = {e0288875},
  doi = {10.1371/journal.pone.0288875}
}
Kostenlos starten →